Mara Goldstein


Analysts Chime in on Two Collapsing Biotech Stocks: Mast Therapeutics Inc (MSTX) and Mirna Therapeutics Inc (MIRN)

The biotech world is sounding the alarm on Mast Therapeutics Inc (NYSEMKT:MSTX) and Mirna Therapeutics Inc (NASDAQ:MIRN) after MSTX now has a Phase …

All Systems Go: Cantor Heads to Sidelines on Applied Genetic Technologies Corp (AGTC)

Applied Genetic Technologies Corp (NASDAQ:AGTC) shares lost 32% of their value today, after the gene therapy company provided a quarterly corporate update, showing that progress …

Cantor Analyst Dives in on Relypsa Inc (RLYP) Following 2Q16 Results

In a research note issued this morning, Cantor analyst Mara Goldstein reiterated a Hold rating on shares of Relypsa Inc (NASDAQ:RLYP) with a price …

Cantor Cuts Price Target for Relypsa Inc (RLYP) Following Acquisition by Galenica

In wake of Galenica buying out Relypsa Inc (NASDAQ:RLYP) for a $1.53 billion deal of $32 per share, Cantor analyst Mara Goldstein has …

Relypsa Inc (RLYP) Jumps Following Acquisition News; Cantor Analyst Weighs In

Shares of Relypsa Inc (NASDAQ:RLYP) jumped 59% to $32 in pre-market trading, after the company announced that it is going to be acquired by …

Biotech Beat: Cantor Weighs In On Oncothyreon Inc (USA) (ONTY) and Galena Biopharma Inc (GALE)

Cantor analyst Mara Goldstein weighed in today on the cancer therapeutics company Oncothyreon Inc (USA) (NASDAQ:ONTY) and biotech company Galena Biopharma Inc (NASDAQ:GALE), with neutral ratings. The analyst …

Here’s Why Cantor Reduced Price Target For Celldex Therapeutics, Inc.

In a research report released earlier today, Cantor analyst Mara Goldstein maintained a Buy rating on shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX), but reduced the …

Galena Biopharma Inc (GALE): The Good and The Bad

Analysts are weighing in today on Galena Biopharma Inc (NASDAQ:GALE) with mixed ratings, as the company released its second-quarter earnings results after the …

Overhang on Sunesis Pharmaceuticals, Inc. Will Persist: Cantor

In a research report issued today, Cantor analyst Mara Goldstein reiterated a Hold rating on shares of Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) with a $2.

Cantor Offers Commentary On Celgene Corporation Following Acquisition Of Receptos Inc

Cantor analyst Mara Goldstein weighed in today with her views on the acquisition of Receptos Inc (NASDAQ:RCPT) by Celgene Corporation (NASDAQ:CELG) that was announced yesterday after-market close. …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts